These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 21455645)
1. Ryanodine receptor type 1 gene mutations found in the Canadian malignant hyperthermia population. Kraeva N; Riazi S; Loke J; Frodis W; Crossan ML; Nolan K; Kraev A; Maclennan DH Can J Anaesth; 2011 Jun; 58(6):504-13. PubMed ID: 21455645 [TBL] [Abstract][Full Text] [Related]
2. Ryanodine receptor mutations in malignant hyperthermia and central core disease. McCarthy TV; Quane KA; Lynch PJ Hum Mutat; 2000; 15(5):410-7. PubMed ID: 10790202 [TBL] [Abstract][Full Text] [Related]
3. Increasing the number of diagnostic mutations in malignant hyperthermia. Levano S; Vukcevic M; Singer M; Matter A; Treves S; Urwyler A; Girard T Hum Mutat; 2009 Apr; 30(4):590-8. PubMed ID: 19191329 [TBL] [Abstract][Full Text] [Related]
4. Mild clinical and histopathological features in patients who carry the frequent and causative malignant hyperthermia RyR1 mutation p.Thr2206Met. Rueffert H; Wehner M; Ogunlade V; Meinecke C; Schober R Clin Neuropathol; 2009; 28(6):409-16. PubMed ID: 19919814 [TBL] [Abstract][Full Text] [Related]
5. Frequency and localization of mutations in the 106 exons of the RYR1 gene in 50 individuals with malignant hyperthermia. Galli L; Orrico A; Lorenzini S; Censini S; Falciani M; Covacci A; Tegazzin V; Sorrentino V Hum Mutat; 2006 Aug; 27(8):830. PubMed ID: 16835904 [TBL] [Abstract][Full Text] [Related]
6. Identification of a novel mutation in the ryanodine receptor gene (RYR1) in a malignant hyperthermia Italian family. Fortunato G; Berruti R; Brancadoro V; Fattore M; Salvatore F; Carsana A Eur J Hum Genet; 2000 Feb; 8(2):149-52. PubMed ID: 10757649 [TBL] [Abstract][Full Text] [Related]
7. Malignant hyperthermia and central core disease causative mutations in Swedish patients. Broman M; Islander G; Müller CR; Ranklev-Twetman E Acta Anaesthesiol Scand; 2007 Jan; 51(1):50-3. PubMed ID: 17081152 [TBL] [Abstract][Full Text] [Related]
8. Identification of malignant hyperthermia-susceptible ryanodine receptor type 1 gene (RYR1) mutations in a child who died in a car after exposure to a high environmental temperature. Nishio H; Sato T; Fukunishi S; Tamura A; Iwata M; Tsuboi K; Suzuki K Leg Med (Tokyo); 2009 May; 11(3):142-3. PubMed ID: 19223216 [TBL] [Abstract][Full Text] [Related]
9. Association of a mutation in the ryanodine receptor 1 gene with equine malignant hyperthermia. Aleman M; Riehl J; Aldridge BM; Lecouteur RA; Stott JL; Pessah IN Muscle Nerve; 2004 Sep; 30(3):356-65. PubMed ID: 15318347 [TBL] [Abstract][Full Text] [Related]
11. Autosomal dominant canine malignant hyperthermia is caused by a mutation in the gene encoding the skeletal muscle calcium release channel (RYR1). Roberts MC; Mickelson JR; Patterson EE; Nelson TE; Armstrong PJ; Brunson DB; Hogan K Anesthesiology; 2001 Sep; 95(3):716-25. PubMed ID: 11575546 [TBL] [Abstract][Full Text] [Related]
12. Identification and biochemical characterization of a novel ryanodine receptor gene mutation associated with malignant hyperthermia. Anderson AA; Brown RL; Polster B; Pollock N; Stowell KM Anesthesiology; 2008 Feb; 108(2):208-15. PubMed ID: 18212565 [TBL] [Abstract][Full Text] [Related]
13. Molecular genetic detection of susceptibility to malignant hyperthermia in Belgian families. Heytens L Acta Anaesthesiol Belg; 2007; 58(2):113-8. PubMed ID: 17710899 [TBL] [Abstract][Full Text] [Related]
14. Mutation screening of the RYR1 gene and identification of two novel mutations in Italian malignant hyperthermia families. Barone V; Massa O; Intravaia E; Bracco A; Di Martino A; Tegazzin V; Cozzolino S; Sorrentino V J Med Genet; 1999 Feb; 36(2):115-8. PubMed ID: 10051009 [TBL] [Abstract][Full Text] [Related]
15. Functional characterization of malignant hyperthermia-associated RyR1 mutations in exon 44, using the human myotube model. Wehner M; Rueffert H; Koenig F; Olthoff D Neuromuscul Disord; 2004 Jul; 14(7):429-37. PubMed ID: 15210166 [TBL] [Abstract][Full Text] [Related]
16. Mutation screening of the RYR1 gene in malignant hyperthermia: detection of a novel Tyr to Ser mutation in a pedigree with associated central cores. Quane KA; Keating KE; Healy JM; Manning BM; Krivosic-Horber R; Krivosic I; Monnier N; Lunardi J; McCarthy TV Genomics; 1994 Sep; 23(1):236-9. PubMed ID: 7829078 [TBL] [Abstract][Full Text] [Related]
17. [Biology of malignant hyperthermia: a disease of the calcium channels of the skeletal muscle]. Monnier N; Lunardi J Ann Biol Clin (Paris); 2000; 58(2):147-56. PubMed ID: 10760701 [TBL] [Abstract][Full Text] [Related]
18. Intracellular calcium homeostasis in human primary muscle cells from malignant hyperthermia-susceptible and normal individuals. Effect Of overexpression of recombinant wild-type and Arg163Cys mutated ryanodine receptors. Censier K; Urwyler A; Zorzato F; Treves S J Clin Invest; 1998 Mar; 101(6):1233-42. PubMed ID: 9502764 [TBL] [Abstract][Full Text] [Related]
19. North American malignant hyperthermia population: screening of the ryanodine receptor gene and identification of novel mutations. Sambuughin N; Sei Y; Gallagher KL; Wyre HW; Madsen D; Nelson TE; Fletcher JE; Rosenberg H; Muldoon SM Anesthesiology; 2001 Sep; 95(3):594-9. PubMed ID: 11575529 [TBL] [Abstract][Full Text] [Related]
20. A case of discordance between genotype and phenotype in a malignant hyperthermia family. Fortunato G; Carsana A; Tinto N; Brancadoro V; Canfora G; Salvatore F Eur J Hum Genet; 1999; 7(4):415-20. PubMed ID: 10352931 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]